This Article Full Text Full Text (PDF) All Versions of this Article: 37/5/1243    most recent 01.STR.0000217970.18319.7dv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Choi, J. H. Articles by Stapf, C. Search for Related Content PubMed PubMed Citation Articles by Choi, J. H. Articles by Stapf, C. Pubmed/NCBI databases Medline Plus Health Information Arteriovenous Malformations Related Collections Health policy and outcome research Related Article

(Stroke. 2006;37:1243.)
© 2006 American Heart Association, Inc.

Original Contributions

Clinical Outcome After First and Recurrent Hemorrhage in Patients With Untreated Brain Arteriovenous Malformation

Jae H. Choi, MD; Henning Mast, MD; Robert R. Sciacca, EngScD; Andreas Hartmann, MD; Alexander V. Khaw, MD; Jay P. Mohr, MD; Ralph L. Sacco, MD Christian Stapf, MD

From the Stroke Center, The Neurological Institute (J.H.C., H.M., R.R.S, A.H., A.V.K., J.P.M., R.L.S., C.S.), New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY; the Department of Neurology, Ernst Moritz Arndt University, Greifswald (A.V.K.), and Bergmannstrost, Halle, Germany (J.H.C., H.M.); the Department of Neurology, Hôpital Lariboisière, AP-HP, Paris, France (C.S.); and the Division of Stroke Medicine (H.M.), Nottingham, UK.

Correspondence to Jae H. Choi, MD, Stroke Center/The Neurological Institute, NI-614, New York-Presbyterian Hospital, Columbia University Medical Center, 710 West 168th Street, New York, NY 10032, USA. E-mail jchoi{at}neuro.columbia.edu

Background and Purpose— The morbidity from spontaneous hemorrhage of untreated brain arteriovenous malformations (AVM) is not well described.

Methods— The 241 consecutive AVM patients (mean age 37±16 years, 52% women) from the prospective Columbia AVM Databank initially presenting with hemorrhage were evaluated using the Rankin Scale (RS) and the National Institute of Health Stroke Scale (NIHSS). From the 241 AVM patients, 29 (12%) had subsequent intracranial hemorrhage during follow-up. For further comparisons, 84 non-AVM patients with intracerebral hemorrhage from the Northern Manhattan Study (NOMAS) served as a control group.

Results— In 241 AVM patients presenting with hemorrhage the median RS was 2 and the median NIHSS was 1 (49% RS 0 to 1, 61% NIHSS <2). The median time between hemorrhage and clinical evaluation was 11 days (mean 219 days). Recurrent AVM hemorrhage during follow-up resulted in no significant increase in morbidity (median RS 2, P=0.004; median NIHSS 3, P=0.322; time between hemorrhage and study evaluation: median 55 days, mean 657 days). Among AVM-hemorrhage subtypes, parenchymatous AVM hemorrhage was associated with higher stroke morbidity (odds ratio, 2.9; 95% CI, 1.5 to 5.8 for NIHSS 2) than nonparenchymatous hemorrhages. Parenchymatous AVM hemorrhage had a significantly better outcome (median NIHSS 1) than non-AVM related hemorrhage (median NIHSS 12; P<0.0001).

Conclusions— Hemorrhage, either at initial presentation or during follow-up of untreated AVM patients appears to carry a lower morbidity than intracranial hemorrhage from other causes. These findings support a careful weighing of risks from interventional treatment and natural history.

Key Words: cerebral arteriovenous malformations • intracerebral hemorrhage • intracranial hemorrhage • outcome • subarachnoid hemorrhage

Related Article:

Unruptured Cerebral Arteriovenous Malformations: To Treat or Not to Treat

Kevin M. Cockroft
Stroke 2006 37: 1148-1149. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				L da Costa, L Thines, A R Dehdashti, M C Wallace, R A Willinsky, M Tymianski, M L Schwartz, and K G t. Brugge Management and clinical outcome of posterior fossa arteriovenous malformations: report on a single-centre 15-year experience J. Neurol. Neurosurg. Psychiatry, April 1, 2009; 80(4): 376 - 379. [Abstract] [Full Text] [PDF]

				J. van Beijnum, C. E. Lovelock, C. Cordonnier, P. M. Rothwell, C. J. M. Klijn, R. Al-Shahi Salman, and on behalf of the SIVMS Steering Committee and the Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies Brain, February 1, 2009; 132(2): 537 - 543. [Abstract] [Full Text] [PDF]

				M. Bendszus and B. Meyer Arteriovenous Malformations of the Brain: Lessons to Learn Stroke, March 1, 2008; 39(3): 741 - 742. [Full Text] [PDF]

				C. Stapf and J.P. Mohr Unruptured Brain Arteriovenous Malformations Should Be Treated Conservatively: Yes Stroke, December 1, 2007; 38(12): 3308 - 3309. [Full Text] [PDF]

				K. M. Cockroft Unruptured Brain Arteriovenous Malformations Should Be Treated Conservatively: No Stroke, December 1, 2007; 38(12): 3310 - 3311. [Full Text] [PDF]

				I. Linfante and A. K. Wakhloo Brain Aneurysms and Arteriovenous Malformations: Advancements and Emerging Treatments in Endovascular Embolization Stroke, April 1, 2007; 38(4): 1411 - 1417. [Abstract] [Full Text] [PDF]

				K. M. Cockroft Unruptured Cerebral Arteriovenous Malformations: To Treat or Not to Treat Stroke, May 1, 2006; 37(5): 1148 - 1149. [Full Text] [PDF]